Is prevention at the heart of UK health policy?
F De Lorenzo - The Lancet, 2022 - thelancet.com
On March 8, 2022, Mr Sajid Javid, former Secretary of State for Health and Social Care, gave
a speech on health-care reform at the Royal College of Physicians in London, UK. 1 Mr …
a speech on health-care reform at the Royal College of Physicians in London, UK. 1 Mr …
Harms of screening for abdominal aortic aneurysm: is there more to life than a 0· 46% disease-specific mortality reduction?
M Johansson, KJ Jørgensen, J Brodersen - The Lancet, 2016 - thelancet.com
For every 10 000 people invited to screening, 46 men avoid dying from a ruptured
abdominal aortic aneurysm. 1, 2 But for every avoided death, four men are diagnosed with …
abdominal aortic aneurysm. 1, 2 But for every avoided death, four men are diagnosed with …
Type 2 diabetes: a two-headed snake in kidney transplant recipients?
S Van Laecke, R Vanholder - The Lancet Diabetes & Endocrinology, 2017 - thelancet.com
Wai Lim and colleagues4 analysed a large registry for the long-term outcomes of 10 714
kidney transplant recipients with or without type 2 diabetes at the time of transplantation …
kidney transplant recipients with or without type 2 diabetes at the time of transplantation …
How can we optimise diabetes care in real-world practice?
JCN Chan - The Lancet Diabetes & Endocrinology, 2017 - thelancet.com
In The Lancet Diabetes & Endocrinology, Kohjiro Ueki and colleagues1 report the results of
J-DOIT3, a multicentre, randomised clinical trial in which 2542 Japanese patients with type 2 …
J-DOIT3, a multicentre, randomised clinical trial in which 2542 Japanese patients with type 2 …
Type 2 diabetes: which drug as add-on to metformin?
S Madsbad - The Lancet, 2012 - thelancet.com
Type 2 diabetes is a progressive disease defined by hyperglycaemia and is associated with
hypertension, dyslipidaemia, and an increased risk of cardiovascular events in most …
hypertension, dyslipidaemia, and an increased risk of cardiovascular events in most …
Maximising use of population data on cardiometabolic diseases
D Flood, D Guwatudde, A Damasceno… - The Lancet Diabetes & …, 2022 - thelancet.com
Comment www. thelancet. com/diabetes-endocrinology Vol 10 March 2022 155 in this
journal, 2 building these health systems requires data that is accurate, timely, and …
journal, 2 building these health systems requires data that is accurate, timely, and …
Drugs and diabetes: understanding the new breed of cardiovascular safety trials
AI Adler - The Lancet Diabetes & Endocrinology, 2013 - thelancet.com
Comment 176 www. thelancet. com/diabetes-endocrinology Vol 1 November 2013 safety
studies are essential to protect the public and provide clinical data, clinicians often have …
studies are essential to protect the public and provide clinical data, clinicians often have …
[引用][C] Increased prevalence of younger onset type 2 diabetes: why and what could be done?
N Sattar, B Kennon, AD White - The Lancet Diabetes & …, 2024 - thelancet.com
Recent studies and national cohort data show alarming rise over the past 5 years in the
number of people younger than 40 years being diagnosed with type 2 diabetes. This …
number of people younger than 40 years being diagnosed with type 2 diabetes. This …
[HTML][HTML] The long Avandia endgame
A Mullard - The Lancet, 2011 - thelancet.com
On July 13, 2010, 33 US Food and Drud Administration (FDA) panellists gathered to
recommend a fate for GlaxoSmithKline's (GSK) Avandia (rosiglitazone) over longstanding …
recommend a fate for GlaxoSmithKline's (GSK) Avandia (rosiglitazone) over longstanding …